Skip to main content
Clinical Trials/IRCT2016032827144N1
IRCT2016032827144N1Completed未知

Study of seroconversion rate of anti-measles antibodyafter vaccination with each measles vaccine strains which are in routine use in Iran(AIK-C and Edmonston-Zagreb) in 9 to 12 months infants of Zahedan District; a randomized controlled trial; Sistan-va-Baluchestan province of Iran; Fall 2015

Centre for Communicable Diseases Control, Ministry of Health and Medical Education0 sites200 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
9 months to 12 months (—)
Sex
All

Inclusion Criteria

  • all children in the mentioned age rang.
  • Exclusion criteria: positive history of inoculation of any kind of measles containing vaccine; being a temporary resident for the next 3 months in the region.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Centre for Communicable Diseases Control, Ministry of Health and Medical Education

Similar Trials